Clinical Trial Update: Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining potential interactions between Coartem and nevirapine, efavirenz, or rifampicin in HIV-infected Ugandan patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Coartem (artemether-lumefantrine)
• Rifadin (rifampin)
• Sustiva (efavirenz)
• Viramune (Nevirapine)

Snippet

Sponsor: Makerere University | Conditions: HIV Infections, Tuberculosis | Phase 4 | Status: UNKNOWN